MYGN - Myriad Genetics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

MYGN is currently covered by 11 analysts with an average price target of $8.23. This is a potential upside of $4.34 (111.57%) from yesterday's end of day stock price of $3.89.

Myriad Genetics's activity chart (see below) currently has 152 price targets and 122 ratings on display. The stock rating distribution of MYGN is 66.67% BUY, 18.52% SELL and 14.81% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 80.52% with an average time for these price targets to be met of 249.05 days.

Highest price target for MYGN is $21, Lowest price target is $6, average price target is $15.63.

Most recent stock forecast was given by DOUG SCHENKEL from COWEN on 07-May-2025. First documented stock forecast 24-Oct-2012.

Split History since 2000:

3/26/09 2 for 1

9/12/00 2 for 1

Currently out of the existing stock ratings of MYGN, 18 are a BUY (66.67%), 5 are a SELL (18.52%), 4 are a HOLD (14.81%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$40

3 days ago
(07-May-2025)

6/7 (85.71%)

$12.07 (43.22%)

117

Buy

$6

$2.11 (54.24%)

$22

3 days ago
(07-May-2025)

7/8 (87.5%)

$1.97 (48.88%)

183

Buy

$10

$6.11 (157.07%)

$19

4 days ago
(06-May-2025)

3/5 (60%)

$5.73 (134.19%)

375

Buy

$8

$4.11 (105.66%)

$14

4 days ago
(06-May-2025)

4/8 (50%)

$3.73 (87.35%)

226

Buy

$20

$16.11 (414.14%)

$34

1 months 10 days ago
(31-Mar-2025)

3/6 (50%)

$11.16 (126.24%)

112

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MYGN (Myriad Genetics) average time for price targets to be met?

On average it took 249.05 days on average for the stock forecasts to be realized with a an average price target met ratio 80.52

Which analyst has the current highest performing score on MYGN (Myriad Genetics) with a proven track record?

ISAAC RO

Which analyst has the most public recommendations on MYGN (Myriad Genetics)?

Isaac Ro has 5 price targets and 3 ratings on MYGN

Which analyst is the currently most bullish on MYGN (Myriad Genetics)?

Drew Jones with highest potential upside - $48.11

Which analyst is the currently most reserved on MYGN (Myriad Genetics)?

Doug Schenkel with lowest potential downside - -$0

Myriad Genetics in the News

Myriad Genetics, Inc. (MYGN): Among Billionaire Larry Robbins’ Stock Picks with Huge Upside Potential

We recently published a list of Billionaire Larry Robbins’ 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Myriad Genetics, Inc. (NASDAQ:MYGN) stands against other stock picks with huge upside potential. Larry Robbins is an American hedge fund manager and philanthropist who founded Glenview Capital...

Down -49.47% in 4 Weeks, Here's Why Myriad (MYGN) Looks Ripe for a Turnaround

A downtrend has been apparent in Myriad Genetics (MYGN) lately with too much selling pressure. The stock has declined 49.5% over the past four weeks. However, given the fact that it is now in oversold territory and Wall Street analysts are majorly in agreement about the company’s ability to report better earnings than they predicted...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?